Artificial Intelligence in Renal Mass Characterization: A Systematic Review of Methodologic Items Related to Modeling, Performance Evaluation, Clinical Utility, and Transparency

被引:24
作者
Kocak, Burak [1 ]
Kaya, Ozlem Korkmaz [2 ]
Erdim, Cagri [3 ]
Kus, Ece Ates [1 ]
Kilickesmez, Ozgur [1 ]
机构
[1] Istanbul Training & Res Hosp, Dept Radiol, TR-34098 Istanbul, Turkey
[2] Koc Univ, Koc Univ Hosp, Dept Radiol, Sch Med, Istanbul, Turkey
[3] Sultangazi Haseki Training & Res Hosp, Dept Radiol, Istanbul, Turkey
关键词
artificial intelligence (AI); machine learning; radiomics; renal cell carcinoma; renal mass; CT TEXTURE ANALYSIS; CELL CARCINOMA; CLEAR-CELL; DIFFERENTIATION; ANGIOMYOLIPOMA; FAT; RADIOMICS; FEATURES; IMAGES;
D O I
10.2214/AJR.20.22847
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to systematically review the literature about the application of artificial intelligence (AI) to renal mass characterization with a focus on the methodologic quality items. MATERIALS AND METHODS. A systematic literature search was conducted using PubMed to identify original research studies about the application of AI to renal mass characterization. Besides baseline study characteristics, a total of 15 methodologic quality items were extracted and evaluated on the basis of the following four main categories: modeling, performance evaluation, clinical utility, and transparency items. The qualitative synthesis was presented using descriptive statistics with an accompanying narrative. RESULTS. Thirty studies were included in this systematic review. Overall, the methodologic quality items were mostly favorable for modeling (63%) and performance evaluation (63%). Even so, the studies (57%) more frequently constructed their work on nonrobust features. Furthermore, only a few studies (10%) had a generalizability assessment with independent or external validation. The studies were mostly unsuccessful in terms of clinical utility evaluation (89%) and transparency (97%) items. For clinical utility, the interesting findings were lack of comparisons with both radiologists' evaluation (87%) and traditional models (70%) in most of the studies. For transparency, most studies (97%) did not share their data with the public. CONCLUSION. To bring AI-based renal mass characterization from research to practice, future studies need to improve modeling and performance evaluation strategies and pay attention to clinical utility and transparency issues.
引用
收藏
页码:1113 / 1122
页数:10
相关论文
共 48 条
  • [1] Clear Cell Renal Cell Carcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis for Prediction of Fuhrman Nuclear Grade
    Bektas, Ceyda Turan
    Kocak, Burak
    Yardimci, Aytul Hande
    Turkcanoglu, Mehmet Hamza
    Yucetas, Ugur
    Koca, Sevim Baykal
    Erdim, Cagri
    Kilickesmez, Ozgur
    [J]. EUROPEAN RADIOLOGY, 2019, 29 (03) : 1153 - 1163
  • [2] Statistical modeling: The two cultures
    Breiman, L
    [J]. STATISTICAL SCIENCE, 2001, 16 (03) : 199 - 215
  • [3] Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model
    Chen, Xi
    Zhou, Zhiguo
    Hannan, Raquibul
    Thomas, Kimberly
    Pedrosa, Ivan
    Kapur, Payal
    Brugarolas, James
    Mou, Xuanqin
    Wang, Jing
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2018, 63 (21)
  • [4] Current Applications and Future Impact of Machine Learning in Radiology
    Choy, Garry
    Khalilzadeh, Omid
    Michalski, Mark
    Do, Synho
    Samir, Anthony E.
    Pianykh, Oleg S.
    Geis, J. Raymond
    Pandharipande, Pari V.
    Brink, James A.
    Dreyer, Keith J.
    [J]. RADIOLOGY, 2018, 288 (02) : 318 - 328
  • [5] A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
    Christodoulou, Evangelia
    Ma, Jie
    Collins, Gary S.
    Steyerberg, Ewout W.
    Verbakel, Jan Y.
    Van Calster, Ben
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2019, 110 : 12 - 22
  • [6] Deep learning and radiomics: the utility of Google TensorFlow Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT
    Coy, Heidi
    Hsieh, Kevin
    Wu, Willie
    Nagarajan, Mahesh B.
    Young, Jonathan R.
    Douek, Michael L.
    Brown, Matthew S.
    Scalzo, Fabien
    Raman, Steven S.
    [J]. ABDOMINAL RADIOLOGY, 2019, 44 (06) : 2009 - 2020
  • [7] Differentiation of renal angiomyolipoma without visible fat from renal cell carcinoma by machine learning based on whole-tumor computed tomography texture features
    Cui, En-Ming
    Lin, Fan
    Li, Qing
    Li, Rong-Gang
    Chen, Xiang-Meng
    Liu, Zhuang-Sheng
    Long, Wan-Sheng
    [J]. ACTA RADIOLOGICA, 2019, 60 (11) : 1543 - 1552
  • [8] Dankers FJWM, 2019, FUNDAMENTALS OF CLINICAL DATA SCIENCE, P101, DOI 10.1007/978-3-319-99713-1_8
  • [9] Machine Learning for Medical Imaging1
    Erickson, Bradley J.
    Korfiatis, Panagiotis
    Akkus, Zeynettin
    Kline, Timothy L.
    [J]. RADIOGRAPHICS, 2017, 37 (02) : 505 - 515
  • [10] Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Escudier, B.
    Porta, C.
    Schmidinger, M.
    Rioux-Leclercq, N.
    Bex, A.
    Khoo, V.
    Gruenvald, V.
    Horwich, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : v58 - v68